search
Back to results

Evaluation of Efficacy of Aloevera in the Treatment of Oral Submucous Fibrosis- A Clinical Study

Primary Purpose

Oral SubMucous Fibrosis

Status
Completed
Phase
Phase 3
Locations
Study Type
Interventional
Intervention
aloevera juice
Hydrocortisone
Hyaluronic Acid
antioxidant
aloevera gel
Sponsored by
The Oxford Dental College, Hospital and Research Center, Bangalore, India
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Oral SubMucous Fibrosis focused on measuring OSMF, Aloevera, Hydrocortisone, Hyaluronidase

Eligibility Criteria

17 Years - 60 Years (Child, Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  1. Clinically diagnosed stage 2 OSMF patients.
  2. Patients who were ready to quit the habit and accept regular follow up protocol.

Exclusion Criteria:

  1. Patients with stage 1 & 3 OSMF.
  2. Patients with history of hypersensitivity to aloevera.
  3. Pregnant women & lactating mothers.
  4. Patients who had undergone any other treatment for OSMF.

Sites / Locations

    Arms of the Study

    Arm 1

    Arm 2

    Arm Type

    Experimental

    Active Comparator

    Arm Label

    aloevera group

    steroid group

    Arm Description

    aloevera juice twice daily for 3 months. aloevera gel one scoop to be applied 3-4 times daily for 3 months

    intralesional injection of hydrocortisone 100mg and injection hyaluronic acid 1500IU once a week for 6 weeks with Capsules SM Fibro once daily for 3 months.

    Outcomes

    Primary Outcome Measures

    burning sensation
    Visual analogue scale
    mouth opening
    interincisal mouth opening was measured using a metal scale and divider from the mesioincisal angle of upper central incisor to the mesioincisal angle of lower central incisor and recorded in millimeters
    cheek flexibility
    Two points were marked, one on each side of the face at 1/3rd the distance from angle of the mouth on a line joining the tragus of the ear and the angle of the mouth. The distance measured between these two points was V2. The subject was asked to blow his cheek fully and the distance measured between the same two points was V1. CF=V2-V1. measured in milimeters
    tongue protrusion
    from mesioincisal angle of upper central incisor to the tip of the tongue when maximally extended with mouth wide open. measured in milimeters

    Secondary Outcome Measures

    Full Information

    First Posted
    February 19, 2016
    Last Updated
    March 15, 2016
    Sponsor
    The Oxford Dental College, Hospital and Research Center, Bangalore, India
    search

    1. Study Identification

    Unique Protocol Identification Number
    NCT02714543
    Brief Title
    Evaluation of Efficacy of Aloevera in the Treatment of Oral Submucous Fibrosis- A Clinical Study
    Study Type
    Interventional

    2. Study Status

    Record Verification Date
    March 2016
    Overall Recruitment Status
    Completed
    Study Start Date
    November 2013 (undefined)
    Primary Completion Date
    August 2015 (Actual)
    Study Completion Date
    November 2015 (Actual)

    3. Sponsor/Collaborators

    Responsible Party, by Official Title
    Principal Investigator
    Name of the Sponsor
    The Oxford Dental College, Hospital and Research Center, Bangalore, India

    4. Oversight

    Data Monitoring Committee
    No

    5. Study Description

    Brief Summary
    Oral submucous fibrosis is a chronic, insidious disease caused by arecanut use and is associated with both significant morbidity (including burning sensation and reduced oral opening) and an increased risk of malignancy. Treatment of Oral SubMucous Fibrosis has largely been symptomatic and is associated with high recurrence rate. Aloevera has immunomodulatory, anti-inflammatory, wound healing, antioxidant and antineoplastic activities. All such properties of Aloevera suggest the possibility of its use in the management of oral submucous fibrosis. In the present study, 74 patients of Oral SubMucous Fibrosis were randomly divided into 2 groups (Group A & B). Group A patients were instructed to drink 30ml of aloe vera juice twice daily before food and to apply 5mg (approx 1 scoop) of aloe vera gel over the lesion 3-4 times daily for 3 months. Group B patients were given intralesional injections of 1.5ml Hydrocortisone acetate 25mg/ml and hyaluronidase (1500 IU) weekly for 6 weeks. They were also prescribed SM Fibro (Alpha lipoic acid 50mg, Beta-carotene 10mg, Elemental copper 1mg, Elemental selenium 75mcg, Lycopene 5mg, Vitamin E 10 IU, Zinc sulphate 27.45mg in form of the capsule) for 3 months. Patients were assessed for burning sensation, interincisal mouthopening, cheek flexibility and tongue protrusion at an interval of 1, 2 and 3 months.
    Detailed Description
    Material and Methods The present study was conducted in the Department of Oral Medicine and Radiology at The Oxford Dental College and Hospital, Bangalore, India between November 2013 to August 2015. Approval from the institutional ethical committee was obtained for the study. Patients with Oral SubMucous Fibrosis (Stage 2 according to Pindborg) were enrolled in the study. Pregnant women, lactating mothers, patients with known history of hypersensitivity to aloevera and those who had received prior treatment for OSMF were excluded. 74 patients who were ready to quit the habit and accept regular follow up treatment protocol were included in the study. An informed consent was obtained from all the patients after the nature of the study and its procedures were explained. A thorough clinical examination was done and the following parameters were measured and recorded by an independent examiner. The intensity of burning sensation was recorded using a Numerical Rating Visual Analogue Scale. The interincisal mouth opening was measured using a metal scale and divider from the mesioincisal angle of upper central incisor to the mesioincisal angle of lower central incisor and recorded in millimeters. Cheek flexibility (CF) was measured according to the method described by Bailoor and Nagesh. Two points were marked, one on each side of the face at 1/3rd the distance from angle of the mouth on a line joining the tragus of the ear and the angle of the mouth. The distance measured between these two points was V2. The subject was asked to blow his cheek fully and the distance measured between the same two points was V1. CF=V2-V1. Tongue protrusion was assessed from normal mesioincisal angle of upper central incisor to the tip of the tongue when maximally extended with mouth wide open. The patients were randomly divided into 2 groups (Group A & B). Group A patients were given pure aloevera gel and pure aloevera juice (Processed and manufactured by Hemant Sai, Sun Vision Company, Neel RLI Pvt Ltd). They were instructed to drink 30ml of aloevera juice twice daily before food and to apply 5mg (approx 1 scoop) of aloevera gel over the lesion 3 times per day for 3 months. Group B patients were given intralesional injections of Hydrocortisone acetate 25mg/ml and hyaluronidase (1500 IU) weekly for 6 weeks. They were also prescribed Cap SM Fibro twice daily for 3 months. Same baseline parameters were measured and recorded at an interval of 1, 2 & 3 months by the same examiner who measured the baseline values and was unaware of the treatment received by the study subjects.

    6. Conditions and Keywords

    Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
    Oral SubMucous Fibrosis
    Keywords
    OSMF, Aloevera, Hydrocortisone, Hyaluronidase

    7. Study Design

    Primary Purpose
    Treatment
    Study Phase
    Phase 3
    Interventional Study Model
    Parallel Assignment
    Masking
    Investigator
    Allocation
    Randomized
    Enrollment
    74 (Actual)

    8. Arms, Groups, and Interventions

    Arm Title
    aloevera group
    Arm Type
    Experimental
    Arm Description
    aloevera juice twice daily for 3 months. aloevera gel one scoop to be applied 3-4 times daily for 3 months
    Arm Title
    steroid group
    Arm Type
    Active Comparator
    Arm Description
    intralesional injection of hydrocortisone 100mg and injection hyaluronic acid 1500IU once a week for 6 weeks with Capsules SM Fibro once daily for 3 months.
    Intervention Type
    Drug
    Intervention Name(s)
    aloevera juice
    Intervention Description
    aloevera juice to drink twice daily for 3 months.
    Intervention Type
    Drug
    Intervention Name(s)
    Hydrocortisone
    Intervention Description
    intralesional injection of hydrocortisone 100mg once a week for 6 weeks
    Intervention Type
    Drug
    Intervention Name(s)
    Hyaluronic Acid
    Intervention Description
    injection hyaluronic acid 1500IU once a week for 6 weeks
    Intervention Type
    Drug
    Intervention Name(s)
    antioxidant
    Other Intervention Name(s)
    Capsule SM Fibro
    Intervention Description
    Capsules SM Fibro (antioxidants) once daily for 3 months.
    Intervention Type
    Drug
    Intervention Name(s)
    aloevera gel
    Intervention Description
    aloevera gel one scoop to be applied 3-4 times daily for 3 months
    Primary Outcome Measure Information:
    Title
    burning sensation
    Description
    Visual analogue scale
    Time Frame
    3 months
    Title
    mouth opening
    Description
    interincisal mouth opening was measured using a metal scale and divider from the mesioincisal angle of upper central incisor to the mesioincisal angle of lower central incisor and recorded in millimeters
    Time Frame
    3 months
    Title
    cheek flexibility
    Description
    Two points were marked, one on each side of the face at 1/3rd the distance from angle of the mouth on a line joining the tragus of the ear and the angle of the mouth. The distance measured between these two points was V2. The subject was asked to blow his cheek fully and the distance measured between the same two points was V1. CF=V2-V1. measured in milimeters
    Time Frame
    3 months
    Title
    tongue protrusion
    Description
    from mesioincisal angle of upper central incisor to the tip of the tongue when maximally extended with mouth wide open. measured in milimeters
    Time Frame
    3 months

    10. Eligibility

    Sex
    All
    Minimum Age & Unit of Time
    17 Years
    Maximum Age & Unit of Time
    60 Years
    Accepts Healthy Volunteers
    No
    Eligibility Criteria
    Inclusion Criteria: Clinically diagnosed stage 2 OSMF patients. Patients who were ready to quit the habit and accept regular follow up protocol. Exclusion Criteria: Patients with stage 1 & 3 OSMF. Patients with history of hypersensitivity to aloevera. Pregnant women & lactating mothers. Patients who had undergone any other treatment for OSMF.

    12. IPD Sharing Statement

    Learn more about this trial

    Evaluation of Efficacy of Aloevera in the Treatment of Oral Submucous Fibrosis- A Clinical Study

    We'll reach out to this number within 24 hrs